These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 33013710)

  • 1. Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome.
    Dewailly D; Barbotin AL; Dumont A; Catteau-Jonard S; Robin G
    Front Endocrinol (Lausanne); 2020; 11():641. PubMed ID: 33013710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.
    Dewailly D; Robin G; Peigne M; Decanter C; Pigny P; Catteau-Jonard S
    Hum Reprod Update; 2016 Nov; 22(6):709-724. PubMed ID: 27566840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.
    Qi X; Pang Y; Qiao J
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():82-7. PubMed ID: 26914398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
    Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian hormone and polycystic ovary syndrome.
    Bhide P; Homburg R
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():38-45. PubMed ID: 27103234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
    Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
    Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F; Liu XL; Rong N; Huang XW
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of the follicular synchronization and sensitivity of rats with PCOS by AMH during prolonged pituitary downregulation.
    Huang J; Ding Y; Li Z
    Gene; 2019 Dec; 721():144106. PubMed ID: 31499126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
    Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women.
    Stracquadanio M; Ciotta L; Palumbo MA
    Gynecol Endocrinol; 2018 Mar; 34(3):223-228. PubMed ID: 28944702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-Mullerian hormone- its role in the pathogenesis of the polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Dimitrakova E; Malinova M; Mladenova M
    Akush Ginekol (Sofiia); 2012; 51(6):22-6. PubMed ID: 23390860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome.
    Du DF; Li XL; Fang F; Du MR
    Gynecol Endocrinol; 2014; 30(12):885-9. PubMed ID: 25170777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome.
    Dumont A; Robin G; Dewailly D
    Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):377-384. PubMed ID: 30299432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells.
    Pellatt L; Rice S; Dilaver N; Heshri A; Galea R; Brincat M; Brown K; Simpson ER; Mason HD
    Fertil Steril; 2011 Nov; 96(5):1246-51.e1. PubMed ID: 21917251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization.
    Desforges-Bullet V; Gallo C; Lefebvre C; Pigny P; Dewailly D; Catteau-Jonard S
    Fertil Steril; 2010 Jun; 94(1):198-204. PubMed ID: 19361798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.